Odonate Therapeutics Stock Quote ODT - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

1.12

Bid

1.11

Ask

1.16

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

16.381M

Previous Close

1.12

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

14,626,000

Dividend Yield

PE Ratio

2.24

Earnings Per Share (EPS)

0.5

Revenue

Net Profit

7.33M

Odonate Therapeutics Inc is a Shell company. Odonate Therapeutics Inc is a Shell company.

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.odonate.com

Headquarters

Wilmington, Delaware, USA

Founded

Odonate Announces Expected Delisting of Its Stock

Odonate Therapeutics, Inc. (NASDAQ: ODT) today announced that on January 6, 2022 it received written notice from The Nasdaq Stock Market LLC (“Nasdaq”) notifying Odonate that Nasdaq believes that...

Odonate Therapeutics Announces Planned Return of Capital to Stockholders through Share Repurchase Plan

Odonate Therapeutics, Inc. (NASDAQ: ODT) today announced that it will commence a share repurchase plan for up to 20 million shares in order to return capital to stockholders. This action is in...

Odonate Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2021

Odonate Therapeutics, Inc. (NASDAQ: ODT) today announced financial results for the three and nine months ended September 30, 2021. As of September 30, 2021, Odonate had $95.0 million in cash...

SHAREHOLDER ALERT: Morris Kandinov Investigating ODT, AYTU, EAR, and CORT; Shareholders are Encouraged to Contact the Firm

SAN DIEGO, Sept. 08, 2021 (GLOBE NEWSWIRE) -- National law firm Morris Kandinov is investigating the actions of the officers and board of directors of Odonate Therapeutics, Inc., Aytu Biopharma...

Odonate Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2021

Odonate Therapeutics, Inc. (NASDAQ: ODT) today announced financial results for the three and six months ended June 30, 2021. In March 2021, Odonate announced the discontinuation of development...

Odonate Therapeutics Announces Financial Results for the Three Months Ended March 31, 2021

Odonate Therapeutics, Inc. (NASDAQ: ODT) today announced financial results for the three months ended March 31, 2021. Odonate recently announced the discontinuation of development of tesetaxel...

Odonate Therapeutics Announces Discontinuation of Development of Tesetaxel

Following feedback from the U.S. Food and Drug Administration (FDA) in a pre-New Drug Application meeting, Odonate Therapeutics, Inc. (NASDAQ: ODT) has concluded that the clinical data package...

Odonate Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2020

Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer, today...

Positive Results of CONTESSA, a Phase 3 Study of Tesetaxel in Patients with Metastatic Breast Cancer, Presented at the 2020 S...

CONTESSA Achieved Primary Endpoint – Tesetaxel Plus a Reduced Dose of Capecitabine Significantly Improved Progression-free Survival (PFS) Versus the Approved Dose of Capecitabine Alone (Hazard...

Odonate Therapeutics Initiates Cohort 3 of CONTESSA TRIO to Evaluate Tesetaxel Monotherapy in Patients with Metastatic Breast...

Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer, today...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

ODT - Frequently Asked Questions (FAQ)

What is the current Odonate Therapeutics share price?

The current share price of Odonate Therapeutics is $ 1.12

How many Odonate Therapeutics shares are in issue?

Odonate Therapeutics has 14,626,000 shares in issue

What is the market cap of Odonate Therapeutics?

The market capitalisation of Odonate Therapeutics is USD 16.38M

What is the 1 year trading range for Odonate Therapeutics share price?

Odonate Therapeutics has traded in the range of $ 0.00 to $ 0.00 during the past year

What is the PE ratio of Odonate Therapeutics?

The price to earnings ratio of Odonate Therapeutics is 2.24

What is the reporting currency for Odonate Therapeutics?

Odonate Therapeutics reports financial results in USD

What is the latest annual profit for Odonate Therapeutics?

The latest annual profit of Odonate Therapeutics is USD 7.33M

What is the registered address of Odonate Therapeutics?

The registered address for Odonate Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Odonate Therapeutics website address?

The website address for Odonate Therapeutics is www.odonate.com

Which industry sector does Odonate Therapeutics operate in?

Odonate Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DRCTDirect Digital Holdings Inc	$ 2.51 (356.36%)	20.87M
RELIReliance Global Group Inc	$ 3.77 (214.17%)	89.84M
TRAWTraws Pharma Inc	$ 13.8152 (175.20%)	23.77M
OCCOptical Cable Corporation	$ 4.89 (132.86%)	5.09M
RAPTRAPT Therapeutics Inc	$ 1.58 (91.42%)	110.12M
AILEiLearningEngines Inc	$ 0.2638 (-70.19%)	10.85M
MGOLMGO Global Inc	$ 0.4249 (-55.27%)	8.21M
TNXPTonix Pharmaceuticals Holding Corporation	$ 0.4139 (-32.33%)	107.37M
YHCLQR House Inc	$ 1.1848 (-32.30%)	925.6k
NVNINVNI Group Ltd	$ 6.10 (-28.90%)	2.39M
EDBLEdible Garden AG Inc	$ 0.4161 (75.05%)	314.62M
RGTIRigetti Computing Inc	$ 11.1601 (19.10%)	164.04M
RAPTRAPT Therapeutics Inc	$ 1.58 (91.42%)	110.12M
TNXPTonix Pharmaceuticals Holding Corporation	$ 0.4139 (-32.33%)	107.37M
RELIReliance Global Group Inc	$ 3.77 (214.17%)	89.84M